HLB Panagene (Biotechnology) Overview
- Year Founded
-
1976
- Status
-
Acquired/Merged
- Employees
-
83
- Latest Deal Type
-
M&A
- Investors
-
4
HLB Panagene (Biotechnology) General Information
Description
HLB Panagene Co Ltd is a South Korea-based company that operates as a specialized bio venture company. The group is developing various technologies and products utilizing PNA (Peptide Nucleic Acid), an artificial gene.
Contact Information
Website
www.hlbpanagene.com(Operating Subsidiary)
Corporate Office
- 54, Techno 10-ro
- Yuseong-gu
- Daejeon, 34027
- South Korea
Corporate Office
- 54, Techno 10-ro
- Yuseong-gu
- Daejeon, 34027
- South Korea
HLB Panagene (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 21-Jun-2023 | Completed | Generating Revenue | |||
| 5. PIPE | 20-Jun-2023 | Completed | Generating Revenue | |||
| 4. PIPE | Completed | Generating Revenue | ||||
| 3. PIPE | 21-Nov-2016 | Completed | Generating Revenue | |||
| 2. IPO | 16-Aug-2000 | Completed | Generating Revenue | |||
| 1. Seed Round | Completed | Startup |
HLB Panagene (Biotechnology) Patents
HLB Panagene (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022203297-A1 | Target nucleic acid amplification method using guide probe and clamping probe and composition for amplifying target nucleic acid comprising same | Inactive | 22-Mar-2021 | ||
| JP-2025118633-A | Highly specific target nucleic acid amplification method and composition for amplifying target nucleic acid using the same | Pending | 24-Nov-2020 | ||
| JP-2023551461-A | Highly specific target nucleic acid amplification method and composition for target nucleic acid amplification using the same | Pending | 24-Nov-2020 | ||
| EP-4253564-A1 | Target nucleic acid amplification method with high specificity and target nucleic acid amplifying composition using same | Pending | 24-Nov-2020 | ||
| EP-4253564-A4 | Target nucleic acid amplification method with high specificity and target nucleic acid amplifying composition using same | Pending | 24-Nov-2020 | C12Q1/6848 |
HLB Panagene (Biotechnology) Signals
HLB Panagene (Biotechnology) Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atinum Investment | Venture Capital | Minority | ||
| Kiwoom Investment | Venture Capital | Minority |
HLB Panagene (Biotechnology) ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Machinery
Industry
Rank
Percentile
Industrial Machinery
Subindustry
Rank
Percentile
HLB Panagene (Biotechnology) FAQs
-
When was HLB Panagene (Biotechnology) founded?
HLB Panagene (Biotechnology) was founded in 1976.
-
Where is HLB Panagene (Biotechnology) headquartered?
HLB Panagene (Biotechnology) is headquartered in Daejeon, South Korea.
-
What is the size of HLB Panagene (Biotechnology)?
HLB Panagene (Biotechnology) has 83 total employees.
-
What industry is HLB Panagene (Biotechnology) in?
HLB Panagene (Biotechnology)’s primary industry is Biotechnology.
-
Is HLB Panagene (Biotechnology) a private or public company?
HLB Panagene (Biotechnology) is a Private company.
-
What is HLB Panagene (Biotechnology)’s current revenue?
The current revenue for HLB Panagene (Biotechnology) is .
-
How much funding has HLB Panagene (Biotechnology) raised over time?
HLB Panagene (Biotechnology) has raised $40.8M.
-
Who are HLB Panagene (Biotechnology)’s investors?
Atinum Investment and Kiwoom Investment have invested in HLB Panagene (Biotechnology).
-
When was HLB Panagene (Biotechnology) acquired?
HLB Panagene (Biotechnology) was acquired on 21-Jun-2023.
-
Who acquired HLB Panagene (Biotechnology)?
HLB Panagene (Biotechnology) was acquired by HLB Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process